Walsall Authorities Crack Down on Illegal Tobacco Sales Operation

Regulations by 2FIRSTS.ai
May.14.2024
Walsall Authorities Crack Down on Illegal Tobacco Sales Operation
Walsall, UK, May 13 - Trading Standards and police raided 5 shops and a van, seizing illegal tobacco worth £20,000.

According to a report from Walsall on May 13th, the Walsall Trading Standards, in conjunction with local police, conducted searches of five retail stores and one commercial vehicle after receiving intelligence about illegal tobacco sales.

 

This action is part of the "CeCe operation" launched jointly by the UK Trading Standards Agency and HM Revenue and Customs, aimed at cracking down on the illegal tobacco market.

 

The department seized over 10,000 cigarettes, 2 kilograms of hand-rolled tobacco, and 700 illegal disposable e-cigarettes, which can deliver up to 15,000 puffs, exceeding the legal limit of 600 puffs. The total value of the confiscated items is approximately £20,000.

 

Currently, local police are continuing to investigate such illegal goods further.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ASDF responds to Malaysia's proposed e-cigarette ban: Implementation prospects remain unclear; urges compliant operations and diversified strategies
ASDF responds to Malaysia's proposed e-cigarette ban: Implementation prospects remain unclear; urges compliant operations and diversified strategies
Regarding the Malaysian government's plan to implement a nationwide ban on the sale and use of e-cigarettes in phases from mid-2026, local e-cigarette brand ASDF told 2Firsts that this move reflects the government's concerns over public health, youth protection and market regulation. However, uncertainties remain regarding the specific implementation methods and pace of enforcement for the policy.
Sep.29
ICYMI: E-cigarette registrations in the UK drop sharply in the latest MHRA update, with 317 new codes approved from Sept 15-21. Prominent brands like IVG and LOST MARY see new device releases, while pod registrations plummet by 82%, with JUUL making a rar
ICYMI: E-cigarette registrations in the UK drop sharply in the latest MHRA update, with 317 new codes approved from Sept 15-21. Prominent brands like IVG and LOST MARY see new device releases, while pod registrations plummet by 82%, with JUUL making a rar
MHRA publicly announced over 300 e-cigarette registration codes, showing a decrease in pod submissions and new brand devices.
Sep.22 by 2FIRSTS.ai
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Rejects State Attorney General's Lawsuit Against E-Cigarette Retailer, Emphasizing FDA Regulatory Authority.
Oct.15 by 2FIRSTS.ai
InterTabac 2025 Insights|Lipstick-Like Design: HAYATI Unveils Pod System, Now Listed on Online Dealer Sites
InterTabac 2025 Insights|Lipstick-Like Design: HAYATI Unveils Pod System, Now Listed on Online Dealer Sites
At InterTabac 2025 in Dortmund, Germany, vaping brand HAYATI showcased its new product Hayati Liora, drawing attention with a lipstick-style exterior. The device uses 2 ml pods and is compatible with both pre-filled and refillable/open pods.
Sep.20 by 2FIRSTS.ai
Special Report | After the Shortage: How the U.S. Vape Market Is Rebuilding Itself
Special Report | After the Shortage: How the U.S. Vape Market Is Rebuilding Itself
After a wave of regulatory crackdowns, the U.S. vaping market is undergoing a deep reshuffle — shortages sparked frenzy, and resupply triggered elimination. Through interviews with industry insiders from both China and the United States, 2Firsts reveals how the American market is rebuilding itself amid turbulence.
Nov.12
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai